It has been documented that tumor cells can induce Tregs in the tumor microenvironment by secreting soluble factors such as TGF-beta, VEGF and GM-CSF, which convert tissue infiltrating CD4+ T cells to Foxp3+ Treg [98, 99]. The gene discussed is FOXP3; the disease is neoplasm.